# A Study of Colesevelam for Lenalidomide-Associated Diarrhea

> **NCT03767257** · PHASE2 · COMPLETED · sponsor: **Memorial Sloan Kettering Cancer Center** · enrollment: 25 (actual)

## Conditions studied

- Multiple Myeloma
- Diarrhea

## Interventions

- **DRUG:** Colesevelam Pill

## Key facts

- **NCT ID:** NCT03767257
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-12-03
- **Primary completion:** 2024-11-27
- **Final completion:** 2024-11-27
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2025-10-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03767257

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03767257, "A Study of Colesevelam for Lenalidomide-Associated Diarrhea". Retrieved via AI Analytics 2026-07-07 from https://api.ai-analytics.org/clinical/NCT03767257. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*